License Agreements (Details) - License agreement with Rasayana Therapeutics, Inc. |
Feb. 18, 2026
USD ($)
period
|
|---|---|
| License Agreements | |
| Upfront payments received | $ 300,000 |
| Potential development milestone payments | 16,000,000 |
| Potential sales milestone payments | $ 22,000,000 |
| Period of termination of agreement | 60 days |
| Number of additional periods for termination of agreement. | period | 1 |
| Additional period within which breach has to be cured to prevent termination | 60 days |
| License termination | 90 days |
| Maximum allowable Period | 180 days |
| X | ||||||||||
- Definition Amount of development milestone payment receivable pursuant to the agreement. No definition available.
|
| X | ||||||||||
- Definition Duration of license termination written notice period. No definition available.
|
| X | ||||||||||
- Definition Amount of cash inflow from upfront payments received by the entity pursuant to agreement. No definition available.
|
| X | ||||||||||
- Definition Amount of sales milestone payment receivable pursuant to the agreement. No definition available.
|
| X | ||||||||||
- Definition Number of additional periods to cure breach for preventing termination of agreement. No definition available.
|
| X | ||||||||||
- Definition Threshold additional period within which breach has to be cured to prevent termination of agreement. No definition available.
|
| X | ||||||||||
- Definition Threshold period within which breach has to be cured to prevent termination of agreement. No definition available.
|
| X | ||||||||||
- Definition The maximum allowable duration for which material development activities may be suspended before the entity becomes entitled to exercise its termination rights under the Agreement. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|